Market Research Industry Reports

Koninklijke Philips N.V. (PHIA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Koninklijke Philips N.V. (Philips) is a diversified technology company develops and manufactures medical systems, consumer electronics and lighting products. The company offers patient care & clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions. It also offers mother and child care, and oral healthcare products include male grooming and beauty products kitchen appliance, coffee, air, garment care, and floor care products and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company provides health & wellness, personal care and domestic appliances. Philips offers consumer luminaires, lumileds, professional lighting solutions, light sources & electronics and automotive lighting. It has operational presence in both mature and growth geographies. The company caters to Healthcare, Consumer Life Style, and Lighting industries. Philips is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips N.V. (PHIA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Biocartis Raises US$40.5 Million In Series E Financing 13
NightBalance Raises Funds in Second Round of Financing 15
NightBalance Raises Funds Through Venture Financing 16
Biocartis Raises US$44.7 Million In Series D Financing 17
Partnerships 19
Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19
Koninklijke Philips Enters into Agreement with Illumina 20
Ion Beam Applications Enters into Agreement with Philips Healthcare 21
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23
Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24
Debt Offering 25
Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25
Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26
Acquisition 27
Philips to Acquire Unisensor, Analytical Instrument Provider 27
Zambon Acquires Profile Pharma from Philips 28
Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To US$42.1 Million 29
Koninklijke Philips N.V. - Key Competitors 31
Koninklijke Philips N.V. - Key Employees 32
Koninklijke Philips N.V. - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee 37
Financial Announcements 38
Apr 23, 2018: Philips First Quarter Results 2018 38
Jan 30, 2018: Philips Fourth Quarter and Annual Results 2017 40
Oct 23, 2017: Philips Third Quarter Results 2017 43
Jul 24, 2017: Philips Second Quarter Results 2017 45
Corporate Communications 48
Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips Board of Management 48
Sep 18, 2017: Philips Steps Up Commitment to Ensuring Healthy Lives for All During United Nations General Assembly Week 49
Jul 20, 2017: Chief Business Leader of Philips Personal Health businesses Pieter Nota to leave company 50
Government and Public Interest 51
Nov 23, 2017: Philips-led research consortium awarded EUR 6.3 million EU grant to develop integrated approaches for personalized cancer treatment 51
Apr 21, 2017: New study with Philips Trilogy reveals payers and hospitals can save millions in readmission costs, hospitalization rates for COPD patients 52
Product News 54
Jun 09, 2017: Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices 54
Other Significant Developments 55
Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 55
Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 56
Sep 14, 2017: Philips reaffirms commitment to patient safety by joining coalition to advance quality and safety in healthcare 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List Of Tables

List of Tables
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Key Facts, 2017 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Biocartis Raises US$40.5 Million In Series E Financing 13
NightBalance Raises Funds in Second Round of Financing 15
NightBalance Raises Funds Through Venture Financing 16
Biocartis Raises US$44.7 Million In Series D Financing 17
Royal Philips and Memorial Sloan Kettering Cancer Center Enter into Research Agreement 19
Koninklijke Philips Enters into Agreement with Illumina 20
Ion Beam Applications Enters into Agreement with Philips Healthcare 21
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 22
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 23
Teva Pharma Industries to Form Joint Venture with Philips Medical Systems 24
Royal Philips Prices Public Offering of Notes Due 2019 for USD596.6 Million 25
Royal Philips Prices Public Offering of Notes Due 2023 for USD596.6 Million 26
Philips to Acquire Unisensor, Analytical Instrument Provider 27
Zambon Acquires Profile Pharma from Philips 28
Volcano Completes Acquisition Of Crux Biomedical, Developer Of Implantable Filter, For Up To US$42.1 Million 29
Koninklijke Philips N.V., Key Competitors 31
Koninklijke Philips N.V., Key Employees 32
Koninklijke Philips N.V., Subsidiaries 33
Koninklijke Philips N.V., Joint Venture 36

List Of Figures

List of Figures
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Koninklijke Philips N.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Koninklijke Philips N.V., Medical Devices Deals, 2012 to YTD 2018 10

Koninklijke Vopak NV (VPK) - Oil and Gas - Deals and Alliances Profile

Koninklijke Vopak NV (Vopak) is an independent tank storage company that stores and handles liquid oil products, chemicals, vegetable oils, biofuels and liquefied natural gases. It also offers logistics services,

USD 250View Report

Koninklijke KPN NV: Performance, Capabilities, Goals and Strategies in the Global Telecom Services Industry

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950View Report

Koninklijke Philips N.V. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Koninklijke Philips N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Koninklijke Philips N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Koninklijke Philips NV Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Koninklijke Philips NV Company Profile is a detailed strategic and analytical report on Koninklijke Philips NV. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :58
Country :Netherlands
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube